{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:03:48Z","timestamp":1740171828336,"version":"3.37.3"},"reference-count":32,"publisher":"Wiley","license":[{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871464","81471767","2013CB733800"],"award-info":[{"award-number":["81871464","81471767","2013CB733800"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["81871464","81471767","2013CB733800"],"award-info":[{"award-number":["81871464","81471767","2013CB733800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Disease Markers"],"published-print":{"date-parts":[[2021,10,6]]},"abstract":"<jats:p>Objective. To assess whether the effectiveness and safety of recanalization therapy for acute ischemic stroke (AIS) caused by large-artery occlusion (LAO) differ between patients aged 60\u201379 years and patients aged \u226580 years. Methods. We analyzed prospective data of patients with LAO (\u226560 years) who underwent recanalization therapy at the Department of Vascular Neurosurgery, New Era Stroke Care and Research Institute, PLA Rocket Force Characteristic Medical Center, from November 2013 to July 2017. The data were compared between elderly patients (60\u201379 years) and very elderly patients (\u226580 years). The effectiveness of recanalization therapy was evaluated using the 90-day modified Rankin scale (mRS) score, while safety was assessed by the rates of symptomatic intracranial hemorrhage (SICH) and mortality within 30 days. Results. A total of 151 patients with AIS induced by LAO were included in this study. Seventy-three patients (48.3% [73\/151]) had an overall favorable outcome (mRS score 0\u20132) after treatment. A higher proportion of patients in the elderly group showed a favorable outcome compared with the very elderly group (58.6% [34\/58] vs. 41.6% [39\/93], respectively; <jats:inline-formula>\n                     <a:math xmlns:a=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\">\n                        <a:mi>P<\/a:mi>\n                        <a:mo>=<\/a:mo>\n                        <a:mn>0.046<\/a:mn>\n                     <\/a:math>\n                  <\/jats:inline-formula>). The incidence of SICH (12.7% vs. 16.13%, respectively; <jats:inline-formula>\n                     <c:math xmlns:c=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\">\n                        <c:mi>P<\/c:mi>\n                        <c:mo>=<\/c:mo>\n                        <c:mn>0.561<\/c:mn>\n                     <\/c:math>\n                  <\/jats:inline-formula>) and mortality (10.3% vs. 7.5%, respectively; <jats:inline-formula>\n                     <e:math xmlns:e=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\">\n                        <e:mi>P<\/e:mi>\n                        <e:mo>=<\/e:mo>\n                        <e:mn>0.548<\/e:mn>\n                     <\/e:math>\n                  <\/jats:inline-formula>) within 30 days was not significantly different between the two groups. Conclusion. Recanalization treatment of LAO is more effective in elderly patients compared with very elderly patients, while the safety of recanalization treatment is comparable between these two groups.<\/jats:p>","DOI":"10.1155\/2021\/3579074","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T10:16:31Z","timestamp":1633601791000},"page":"1-9","source":"Crossref","is-referenced-by-count":1,"title":["Recanalization Treatment of Acute Ischemic Stroke Caused by Large-Artery Occlusion in the Elderly: A Comparative Analysis of \u201cthe Elderly\u201d and \u201cthe Very Elderly\u201d"],"prefix":"10.1155","volume":"2021","author":[{"given":"Qi","family":"Wang","sequence":"first","affiliation":[{"name":"The PLA Rocket Force Characteristic Medical Center, The Teaching Hospital of Soochow University, Beijing, China"},{"name":"Department of Vascular Neurosurgery, New Era Stroke Care and Research Institute, Department of Neurology, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Qun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Vascular Neurosurgery, New Era Stroke Care and Research Institute, The PLA Rocket Force Characteristic Medical Center, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Cheng","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Vascular Neurosurgery, New Era Stroke Care and Research Institute, The PLA Rocket Force Characteristic Medical Center, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Dan","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Vascular Neurosurgery, New Era Stroke Care and Research Institute, The PLA Rocket Force Characteristic Medical Center, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ao-Fei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Vascular Neurosurgery, New Era Stroke Care and Research Institute, The PLA Rocket Force Characteristic Medical Center, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Vascular Neurosurgery, New Era Stroke Care and Research Institute, The PLA Rocket Force Characteristic Medical Center, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9594-747X","authenticated-orcid":true,"given":"Wei-Jian","family":"Jiang","sequence":"additional","affiliation":[{"name":"The PLA Rocket Force Characteristic Medical Center, The Teaching Hospital of Soochow University, Beijing, China"},{"name":"Department of Vascular Neurosurgery, New Era Stroke Care and Research Institute, The PLA Rocket Force Characteristic Medical Center, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.505776"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1177\/1747493020913557"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1111\/ijs.12618"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411587"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414792"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414905"},{"issue":"3","key":"7","first-page":"267","article-title":"Scientific statement of Chinese Stroke Association on intravenous thrombolysis in acute ischemic stroke","volume":"12","author":"Expert group of scientific statement of Chinese Stroke association","year":"2017","journal-title":"Chinese Journal of Stroke"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0b013e318284056a"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2018-013787"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00163-X"},{"issue":"7","key":"11","first-page":"706","article-title":"Intravascular therapy for acute ischemic stroke","volume":"13","author":"Chinese stroke association","year":"2018","journal-title":"Chinese Journal Stroke"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2016.08.037"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006667"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2018-014289"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.12.015"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.01.008"},{"issue":"12","key":"17","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.06.060","article-title":"Mechanical thrombectomy for acute ischemic stroke patients aged 80 years or older Mechanical thrombectomy for acute ischemic stroke in elderly","volume":"26","author":"T. Imahori","year":"2017","journal-title":"Journal of Stroke and Cerebrovascular Deseases"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1177\/1971400919840847"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2015-011702"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1415061"},{"issue":"10","key":"21","first-page":"1852","article-title":"Safety and effectiveness of intravenous thrombolysis with recombinant tissue plasminogen activator in eighty years and older acute ischemic stroke patients","volume":"19","author":"Y. Chen","year":"2015","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"11","key":"22","first-page":"899","article-title":"Interpretation of \u201cChinese guidelines for diagnosis and treatment of acute ischemic stroke 2018\u201d","volume":"19","author":"Z. Di","year":"2019","journal-title":"Chinese Journal of Contemporary Neurology and Neurosurgery"},{"issue":"6","key":"23","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.007","article-title":"Thrombolysis in patients aged over 80 years is equally effective and safe, Thrombolysis in patients over 80 years is effective and safe","volume":"25","author":"J. Z. Willey","year":"2016","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1016\/S1052-3057(03)00042-9"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.5551\/jat.43240"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.017320"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.01.007"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2020-000388"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22579-0"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1042\/CS20130284"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-016-0821-z"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0549-8"}],"container-title":["Disease Markers"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/dm\/2021\/3579074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/dm\/2021\/3579074.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/dm\/2021\/3579074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T13:57:22Z","timestamp":1642859842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/dm\/2021\/3579074\/"}},"subtitle":[],"editor":[{"given":"Xianwei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":32,"alternative-id":["3579074","3579074"],"URL":"https:\/\/doi.org\/10.1155\/2021\/3579074","relation":{},"ISSN":["1875-8630","0278-0240"],"issn-type":[{"type":"electronic","value":"1875-8630"},{"type":"print","value":"0278-0240"}],"subject":[],"published":{"date-parts":[[2021,10,6]]}}}